REGINA, SK, June 6, 2025 /PRNewswire/ - Above Food Ingredients Inc. (NASDAQ: ABVE) ("the Company"), acknowledges receipt of a formal notification from The Nasdaq Stock Market LLC regarding non-compliance with Listing Rule 5450(b)(3)(C), regarding minimum market value of publicly held shares (PR market value). The company is very pleased that this condition has been met as of May 27, 2025.Furthermore, the Company is very pleased that, as of May 27, 2025, it has met Listing Rules 5810(c)(3)(A) and 5450(a)(1) ...

【SynBioCon】 获悉， 近日，《Fertilizer Daily》报道称，美国一批领先的生物技术企业宣布成立 美国 生物制造联盟（AAB） ，这是一个致力于提高美国生物制造能力的新行业联盟。该联盟旨在促进国内创 新，提高供应链的弹性，并扩大美国在快速发展的全球生物经济中的影响力。 联盟于5月21日成立，汇集了整个生物制造领域的利益相关者，包括 Manus、Pivot Bio、Novonesis North America、Kula Bio和 LanzaTech Global 等公司的首席执行官和高管 。据了解，该联盟是在新兴生 物技术国家安全委员会（NSCEB）最近呼吁制定协调一致的国家战略以加强美国在该领域的领导地位之后 成立的。 "生物制造不再仅仅是一个科学机遇，而是一项战略要务。"Manus首席执行官Ajikumar Parayil说，"该联 盟的成立，代表生物制造行业向着创新与创造就业、供应链安全和竞争力相结合的方向迈进了一步。" 生物制造广泛应用于农业、能源、化工、材料、营养和制药等多个领域，利用细胞、酶或微生物等生物材 料来生产可持续塑料和肥料、食品配料和生物燃料等各种产品。目前，全球生物 ...

Financial Data and Key Metrics Changes - IFF generated approximately $2.8 billion in sales for Q1 2025, representing a 3% comparable currency neutral growth [10] - Adjusted operating EBITDA totaled $578 million for the quarter, a strong 9% increase on a comparable currency neutral basis [10] - Comparable currency neutral adjusted operating EBITDA margin increased more than 120 basis points to 20.3% [10] Business Line Data and Key Metrics Changes - Pharma Solutions delivered $266 million in sales, an 8% year-over-year increase on a comparable currency neutral basis [11] - Taste segment sales were $627 million, a 7% year-over-year increase on a comparable currency neutral basis [13] - Food Ingredients had sales of $796 million, a 4% comparable currency neutral decrease from the prior year [13] - Health and Biosciences segment delivered a 5% increase in comparable currency neutral sales [14] - Scent achieved net sales of $614 million, up 4% year-over-year on a comparable currency neutral basis [14] Market Data and Key Metrics Changes - The company noted that broader macroeconomic dynamics remain challenging, but IFF's portfolio is grounded in resilient essential end markets [20] - The company expects approximately 2% adverse impact on revenue from foreign exchange, down from 4% previously [22] Company Strategy and Development Direction - IFF is focused on strengthening its business through consistent reinvestment in core growth drivers: R&D, commercial, digital, and capacity [20] - The company is maintaining its full-year guidance ranges despite macroeconomic uncertainties [21] - IFF completed the divestiture of Pharma Solutions, which strengthens its capital structure and helps achieve a net debt to credit adjusted EBITDA ratio of below three times [7][17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the order book remaining consistent with guidance despite macroeconomic uncertainties [28] - The company is actively working with customers to mitigate impacts of tariff actions and remains disciplined in response to macroeconomic uncertainty [9] - Management acknowledged concerns about potential recessionary pressures but emphasized the resilience of 80% of its portfolio in essential products [29] Other Important Information - Cash flow from operations totaled $127 million year-to-date, with CapEx at $179 million, approximately 6% of sales [15] - Gross debt was approximately $9.3 billion, a decrease of more than $1 billion compared to the year-ago period [17] Q&A Session All Questions and Answers Question: Can you talk us through which areas of the portfolio could potentially be at risk and which parts could be more resilient in a recessionary scenario? - Management indicated that 80% of the portfolio is in essential products, which are resilient, while discretionary areas like fine fragrances may be at risk [29] Question: Can you disclose what you think the gross impact today is on your costs from tariffs? - Management noted a gross exposure of over $100 million for 2025 related to tariffs, primarily from China, but emphasized successful supply chain optimization efforts [35] Question: What were the year-ago comps for flavors and food ingredients? - Management reported that Taste grew 11% last year in Q1, while Food Ingredients declined 4% last year [40] Question: Can you elaborate on the strategic rationale for the joint venture with Chimera? - The joint venture aims to scale enzymatic biomaterials and is expected to start operations by the end of 2027, targeting high-value biodegradable polymers [44][46] Question: What drove volumes lower in protein solutions? - Management indicated that volumes were down due to weaker performance in lower-value areas and production issues in higher-value areas, which are being resolved [55] Question: How do you see the inventory cycle affecting IFF? - Management expressed that they do not believe inventory levels are elevated enough to cause a significant downtick, given the recent destocking period [88]

Darling Ingredients (DAR) reported $1.38 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 2.8%. EPS of -$0.16 for the same period compares to $0.50 a year ago.The reported revenue represents a surprise of -8.36% over the Zacks Consensus Estimate of $1.51 billion. With the consensus EPS estimate being $0.20, the EPS surprise was -180.00%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall ...

Core Viewpoint - Above Food Ingredients Inc. is actively addressing compliance issues with Nasdaq and is optimistic about regaining compliance ahead of the scheduled hearing on May 22, 2025 [1][2]. Group 1: Compliance Issues - The company received a notice on October 10, 2024, indicating non-compliance with Nasdaq's minimum bid price requirement, as its closing bid price was below $1.00 per share for 30 consecutive business days [2]. - The company has requested a hearing and an extended stay in response to a staff determination notice received on April 14, 2025, and is confident in meeting compliance requirements before the hearing [1][2]. Group 2: Financial Restructuring - A significant restructuring announced on March 20, 2025, has improved the company's financial position by eliminating most corporate debt and advancing towards operational profitability [2]. - The successful closing of the Palm transaction, first announced on February 6, 2025, is expected to materially enhance shareholder value [2]. Group 3: Reporting Compliance - Due to the restructuring, the company has not yet filed its interim balance sheet and income statement for the period ended July 31, 2024, which is a violation of Listing Rule 5250(c)(2) [3]. - The company plans to remedy this deficiency by filing the required Form 6-K before April 30, 2025, ahead of the hearing date [3]. Group 4: Company Overview - Above Food Ingredients Inc. is an ingredient company focused on delivering nutritious products made with real ingredients, emphasizing transparency and sustainability [4]. - The company aims to create a healthier world through its operations in primary agriculture and processing, leveraging artificial intelligence-driven genomics and agronomy [4].

Core Viewpoint - Analysts project that Darling Ingredients (DAR) will report quarterly earnings of $0.36 per share, reflecting a 28% decline year over year, while revenues are expected to reach $1.51 billion, marking a 6.1% increase from the same quarter last year [1]. Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been adjusted downward by 4.6%, indicating a reassessment by covering analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3]. Revenue and Sales Projections - The consensus estimate for 'Net Sales- Feed Ingredients' is $976.29 million, representing a 9.7% increase from the prior-year quarter [5]. - 'Net Sales- Fuel Ingredients' is projected to reach $137.58 million, indicating a 1.1% decline from the prior-year quarter [5]. - 'Net Sales- Food Ingredients' is expected to be $376.23 million, reflecting a 3.9% decrease from the year-ago quarter [5]. EBITDA Estimates - 'Segment Adjusted EBITDA- Food Ingredients' is anticipated to be $66.29 million, up from $61.69 million in the same quarter last year [6]. - 'Segment Adjusted EBITDA- Feed Ingredients' is projected at $151.08 million, compared to $106.81 million in the previous year [6]. - 'Segment Adjusted EBITDA- Fuel Ingredients' is expected to be $19.87 million, an increase from $18.08 million reported in the same quarter last year [7]. Stock Performance - Darling shares have increased by 3.3% over the past month, contrasting with the Zacks S&P 500 composite's decline of 5.6% [7]. - With a Zacks Rank 5 (Strong Sell), DAR is expected to underperform the overall market in the near term [7].